Clinical Trials Directory

Trials / Completed

CompletedNCT02894541

Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519

A Randomized, Open-label, Single Dose, 1-sequence, 3-treatment, 3-period Crossover Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519 in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Chong Kun Dang Pharmaceutical · Industry
Sex
Male
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the effects of food on the pharmacokinetics/pharmacodynamics of CKD-519.

Detailed description

A randomized, open-label, single dose, 1-sequence, 3-treatment, 3-period crossover study to investigate the effects of food on the pharmacokinetics/pharmacodynamics of CKD-519 in healthy male subjects.

Conditions

Interventions

TypeNameDescription
DRUGCKD-519 100mg
DRUGCKD-519 200mg
DRUGCKD-519 100mg
DRUGCKD-519 200mg

Timeline

Start date
2016-08-01
Primary completion
2016-11-01
Completion
2017-01-01
First posted
2016-09-09
Last updated
2017-02-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02894541. Inclusion in this directory is not an endorsement.